Carcinoma of the stomach is still the second most common cause of cancer death
worldwide, although the incidence and mortality have fallen dramatically over the last 50 …

Gastric cancer remains a global killer with a shifting burden from the developed to the
developing world. The cancer develops along a multistage process that is defined by distinct …

It has been postulated that chronic atrophic gastritis, intestinal metaplasia, and dysplasia are
precancerous stages of stomach tumorigenesis. We investigated the timing of p53 …

Gene changes in multiple oncogenes, multiple growth factors and multiple tumor-suppressor
genes are observed in stomach cancer. Among them, those most commonly implicated in …

Gastric cancer is of major importance world-wide being the second most common cause of
cancer-related death in the world. According to Lauren's histological classification gastric …

Simple Summary The p53 family is a complex family of transcription factors with different
cellular functions that are involved in several physiological processes. A massive amount of …

Background A recent randomized controlled trial (Trastuzumab for Gastric Cancer [ToGA]
study) established standard scoring criteria of human epidermal growth factor receptor 2 …

Genetic and epigenetic alterations of multiple cancer-related genes and molecules are
implicated in the development and progression of human gastric carcinomas. Reactivation …

Despite a plateau in incidence, gastric cancer remains a significant problem globally. The
majority of gastric cancer is associated with histologically recognizable premalignant stages …

The present study was directed towards the identification of novel factors involved in the
transformation process leading to the formation of gastric cancer. A cDNA library from …